What does CUSIP 86627T108 represent in this 13F holders report?

CUSIP 86627T108 is the security identifier for SMMT - Summit Therapeutics Inc. - COM used to aggregate holder disclosures.

How many institutions held SMMT - Summit Therapeutics Inc. - COM in Q3 2022?

37 institutional investors reported SMMT - Summit Therapeutics Inc. - COM for Q3 2022. Use the holders table for investor-level position and value details.

Summit Therapeutics Inc. - COM (SMMT)

CUSIP: 86627T108

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / COM
Total 13F shares: 3,172,802
Share change: -5,284,016
Total reported value: $3,773,379
Price per share: $1.19
Number of holders: 37
Value change: -$5,112,229
Number of buys: 22
Number of sells: 11

Security key

86627T108

Report period

Q3 2022

Institutions

Top holders

SMMT full security history Newer quarter: Q4 2022 Previous quarter: Q2 2022 Summit Therapeutics Inc. SEC filings Summit Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 86627T108

Newer quarter: Q4 2022 Previous quarter: Q2 2022

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SMMT - Summit Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Polar Capital Holdings Plc	13F	Company	— class O/S missing	5,599,407	$5,599,000	—	30 Jun 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	775,922	$776,000	—	30 Jun 2022	13F
Urte Gayko	3/4/5	Director	— class O/S missing	400,000	$528,000	—	25 Apr 2022	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	— class O/S missing	457,468	$457,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	302,208	$302,000	—	30 Jun 2022	13F
Alpine Global Management, LLC	13F	Company	— class O/S missing	300,000	$300,000	—	30 Jun 2022	13F
MORGAN STANLEY	13F	Company	— class O/S missing	208,673	$209,000	—	30 Jun 2022	13F
Ergoteles LLC	13F	Company	— class O/S missing	100,722	$101,000	—	30 Jun 2022	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	89,100	$89,000	—	30 Jun 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	— class O/S missing	81,559	$82,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	— class O/S missing	63,336	$63,000	—	30 Jun 2022	13F
CITADEL ADVISORS LLC	13F	Company	— class O/S missing	56,551	$57,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	54,355	$54,000	—	30 Jun 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— class O/S missing	49,118	$49,000	—	30 Jun 2022	13F
MERCER GLOBAL ADVISORS INC /ADV	13F	Company	— class O/S missing	40,200	$40,000	—	30 Jun 2022	13F
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	— class O/S missing	39,176	$39,000	—	30 Jun 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	— class O/S missing	34,393	$34,000	—	30 Jun 2022	13F
HoyleCohen, LLC	13F	Company	— class O/S missing	30,432	$30,000	—	30 Jun 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	— class O/S missing	23,637	$24,000	—	30 Jun 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	20,900	$21,000	—	30 Jun 2022	13F
Jeffrey R. Maranian	3/4/5	VP Corporate Controller	— class O/S missing	15,000	$19,800	—	15 Dec 2021	3/4/5
Qube Research & Technologies Ltd	13F	Company	— class O/S missing	18,811	$19,000	—	30 Jun 2022	13F
COWEN AND COMPANY, LLC	13F	Company	— class O/S missing	18,049	$18,000	—	30 Jun 2022	13F
Inscription Capital, LLC	13F	Company	— class O/S missing	17,000	$17,000	—	30 Jun 2022	13F
BENDER ROBERT & ASSOCIATES	13F	Company	— class O/S missing	14,059	$14,000	—	30 Jun 2022	13F
VANCE WEALTH, LLC	13F	Company	— class O/S missing	13,299	$13,000	—	30 Jun 2022	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	— class O/S missing	11,445	$11,000	—	30 Jun 2022	13F
OSAIC HOLDINGS, INC.	13F	Company	— class O/S missing	10,600	$11,000	—	30 Jun 2022	13F
Y-Intercept (Hong Kong) Ltd	13F	Company	— class O/S missing	10,355	$10,000	—	30 Jun 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	9,363	$9,000	—	30 Jun 2022	13F
JPMORGAN CHASE & CO	13F	Company	— class O/S missing	5,135	$6,000	—	30 Jun 2022	13F
EVOKE WEALTH, LLC	13F	Company	— class O/S missing	5,000	$5,000	—	30 Jun 2022	13F
NATIONAL BANK OF CANADA /FI/	13F	Company	— class O/S missing	3,241	$3,000	—	30 Jun 2022	13F
ADIRONDACK TRUST CO	13F	Company	— class O/S missing	2,500	$3,000	—	30 Jun 2022	13F
Ten Capital Wealth Advisors, LLC	13F	Company	— class O/S missing	2,000	$2,000	—	30 Jun 2022	13F
CITIGROUP INC	13F	Company	— class O/S missing	1,720	$2,000	—	30 Jun 2022	13F
HARBOUR INVESTMENTS, INC.	13F	Company	— class O/S missing	1,300	$1,000	—	30 Jun 2022	13F
Worth Asset Management, LLC	13F	Company	— class O/S missing	1,000	$1,000	—	30 Jun 2022	13F
BARCLAYS PLC	13F	Company	— class O/S missing	961	$1,000	—	30 Jun 2022	13F

Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2022

As of 30 Sep 2022, Summit Therapeutics Inc. - COM (SMMT) was held by 37 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,172,802 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, and UBS Group AG. This page lists 37 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.